Search

iRhythm Technologies Inc

Chiusa

SettoreSettore sanitario

123.22 -3.52

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

122.18

Massimo

123.77

Metriche Chiave

By Trading Economics

Entrata

14M

-381K

Vendite

25M

224M

EPS

0.58

Margine di Profitto

-0.17

Dipendenti

2,400

EBITDA

13M

9.7M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+41.61% upside

Dividendi

By Acuity

Utili prossimi

5 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-77M

4B

Apertura precedente

126.74

Chiusura precedente

123.22

iRhythm Technologies Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

30 ott 2026, 20:03 UTC

iRhythm Holdings, Inc. shares fell sharply, reaching a session low, in contrast to the prior six sessions that all closed higher.

29 ott 2026, 20:07 UTC

iRhythm Holdings, Inc. shares advanced significantly during Thursday's trading, continuing a climb that began since Wednesday's close and remaining well above its 20-day moving average.

27 ott 2026, 19:56 UTC

iRhythm Holdings, Inc. is trading higher, having reached a peak earlier in the session after four consecutive days of gains, remaining above its 20-day moving average.

23 ott 2026, 20:07 UTC

iRhythm Holdings, Inc. shares are advancing, supported by a strong broader market, and remain above their 20-day moving average.

22 ott 2026, 20:02 UTC

iRhythm Holdings, Inc. is experiencing a sharp increase amid a broader trend of rising daily closes since Wednesday's close.

21 ott 2026, 19:46 UTC

iRhythm Holdings, Inc. shares fell modestly on Wednesday, retracing from an early gain and remaining above the 20-day moving average.

20 ott 2026, 20:01 UTC

iRhythm Holdings, Inc. is trading significantly higher, reaching a session high earlier, and remains above its 20-day moving average.

19 ott 2026, 20:07 UTC

iRhythm Holdings, Inc. is advancing, having gained modestly since Friday's close while trading within the middle of its one-month range.

16 ott 2026, 20:07 UTC

News

Piper Sandler initiated coverage on iRhythm Holdings with an Overweight rating and a price target of $160, citing an overdone year-to-date selloff.

15 ott 2026, 22:56 UTC

News

iRhythm Holdings, Inc. shares declined in after-market hours following Thursday's close, amid broader market trends, ahead of third-quarter results on November 5.

14 ott 2026, 20:31 UTC

Shares down sharply in after-market trading since Wednesday's close.

9 ott 2026, 20:06 UTC

News

iRhythm Holdings is under investigation for a cybersecurity incident and has updated its operational and financial guidance, as shares gain amid a broader market rebound.

8 ott 2026, 20:07 UTC

iRhythm Holdings, Inc. shares are declining, continuing a seven-session downward trend amid ongoing market weakness and remaining significantly below their 20-day moving average.

7 ott 2026, 20:07 UTC

iRhythm Holdings, Inc. shares fell sharply, continuing a six-session decline and remaining significantly below the 20-day moving average.

6 ott 2026, 20:31 UTC

iRhythm Holdings, Inc. is down in after-market trading, marking six consecutive lower daily finishes and trading below its 20-day moving average.

2 ott 2026, 20:07 UTC

iRhythm Holdings, Inc. shares fell modestly as the broader market declined, closing near the lower end of its range and below its 20-day moving average.

1 ott 2026, 20:07 UTC

iRhythm Holdings, Inc. shares fell sharply, reaching a low in the late morning and trading near the lower end of its one-month range.

30 set 2026, 19:46 UTC

iRhythm Holdings, Inc. shares fell sharply, currently trading below its 20-day moving average and near the lower end of its one-month range.

29 set 2026, 19:41 UTC

iRhythm Holdings, Inc. is advancing, continuing its upward trend since Monday, amid positive movement in the broader health care equipment sector.

28 set 2026, 20:01 UTC

iRhythm Holdings, Inc. is advancing, continuing its upward trend since Friday's close, despite mixed performance in the broader health care equipment sector.

23 set 2026, 19:52 UTC

iRhythm Holdings, Inc. is advancing, continuing a trend of gains since Tuesday's close, despite earlier pulling back from a session high.

21 set 2026, 19:25 UTC

iRhythm Holdings, Inc. is advancing, continuing gains since Friday's close, despite earlier pulling back from a session high amid broader market strength.

18 set 2026, 19:16 UTC

iRhythm Holdings, Inc. shares fell sharply, remaining significantly below their 20-day moving average and near the lower end of their one-month trading range.

17 set 2026, 20:07 UTC

iRhythm Holdings, Inc. shares fell modestly, retracing from an early spike and settling near the lower end of its one-month trading range.

16 set 2026, 19:16 UTC

iRhythm Holdings, Inc. is trading modestly higher, with a cumulative return peaking at 0.79%, though still below its 20-day moving average.

15 set 2026, 22:31 UTC

iRhythm Holdings shows little change in after-hours trading, remaining significantly below its 20-day moving average amid broader performance weakness.

14 set 2026, 20:08 UTC

iRhythm Holdings, Inc. shares are higher today, recovering after five consecutive days of declines, though still below the 20-day moving average.

11 set 2026, 19:26 UTC

iRhythm Holdings, Inc. shares are lower today, continuing a trend with five consecutive daily declines amid steady inflation data influencing Federal Reserve policy.

10 set 2026, 20:03 UTC

News

iRhythm Holdings shares are trading lower amid an investigation into potential corporate wrongdoing by the company and certain officers, announced by Bronstein, Gewirtz & Grossman.

9 set 2026, 20:07 UTC

iRhythm Holdings, Inc. shares are lower amid a volatile session, trading significantly below their 20-day moving average after three consecutive daily declines.

Confronto tra pari

Modifica del prezzo

iRhythm Technologies Inc Previsione

Obiettivo di Prezzo

By TipRanks

41.61% in crescita

Previsioni per 12 mesi

Media 174.7 USD  41.61%

Alto 196 USD

Basso 150 USD

Basato su 13 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per iRhythm Technologies Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

13 ratings

13

Acquista

0

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat